In humans, tumor or virally infected target cells increased expression of activating NKG2D ligands (referred as NKG2DL hereafter), such as ULBP1–6(8–10) and MIC-A/B(9, 11) and downregulate MHC class I expressions (12). This evidence concerns the gene KLRK1 and neoplasm.